Cargando…

Urgent need to expand syringe services programs in South Carolina and beyond

Opioid related overdose deaths in the United States claimed over 100,000 thousand lives during the 12-month period ending in April 2021, an increase of 28.5% from the previous period. Syringe services programs (SSPs) are an evidence-based harm reduction strategy that have been shown to be effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, Quang, Burrows, Marc, Litwin, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210717/
https://www.ncbi.nlm.nih.gov/pubmed/35729624
http://dx.doi.org/10.1186/s13011-022-00476-0
_version_ 1784730214560956416
author Pham, Quang
Burrows, Marc
Litwin, Alain
author_facet Pham, Quang
Burrows, Marc
Litwin, Alain
author_sort Pham, Quang
collection PubMed
description Opioid related overdose deaths in the United States claimed over 100,000 thousand lives during the 12-month period ending in April 2021, an increase of 28.5% from the previous period. Syringe services programs (SSPs) are an evidence-based harm reduction strategy that have been shown to be effective in reducing opioid overdose deaths and infectious complications and increasing rates of entry into recovery programs. Ignoring this evidence, South Carolina (SC) and several states have yet to legalize SSPs. In the absence of full legalization, the operation of SSPs in SC faces many barriers. Despite these barriers, Challenges Inc. has been successful in playing a critical role in preventing opioid overdoses through naloxone and fentanyl test strip distribution, reducing infectious complications by providing clean needles, treating individuals with hepatitis C and HIV, and helping patients remain in sustained recovery from opioids. In order for SSPs to function at their full potential to curb the rising tides of opioid overdose deaths and related health complications, policymakers in SC and similar states need to urgently legalize them.
format Online
Article
Text
id pubmed-9210717
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92107172022-06-22 Urgent need to expand syringe services programs in South Carolina and beyond Pham, Quang Burrows, Marc Litwin, Alain Subst Abuse Treat Prev Policy Comment Opioid related overdose deaths in the United States claimed over 100,000 thousand lives during the 12-month period ending in April 2021, an increase of 28.5% from the previous period. Syringe services programs (SSPs) are an evidence-based harm reduction strategy that have been shown to be effective in reducing opioid overdose deaths and infectious complications and increasing rates of entry into recovery programs. Ignoring this evidence, South Carolina (SC) and several states have yet to legalize SSPs. In the absence of full legalization, the operation of SSPs in SC faces many barriers. Despite these barriers, Challenges Inc. has been successful in playing a critical role in preventing opioid overdoses through naloxone and fentanyl test strip distribution, reducing infectious complications by providing clean needles, treating individuals with hepatitis C and HIV, and helping patients remain in sustained recovery from opioids. In order for SSPs to function at their full potential to curb the rising tides of opioid overdose deaths and related health complications, policymakers in SC and similar states need to urgently legalize them. BioMed Central 2022-06-21 /pmc/articles/PMC9210717/ /pubmed/35729624 http://dx.doi.org/10.1186/s13011-022-00476-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Comment
Pham, Quang
Burrows, Marc
Litwin, Alain
Urgent need to expand syringe services programs in South Carolina and beyond
title Urgent need to expand syringe services programs in South Carolina and beyond
title_full Urgent need to expand syringe services programs in South Carolina and beyond
title_fullStr Urgent need to expand syringe services programs in South Carolina and beyond
title_full_unstemmed Urgent need to expand syringe services programs in South Carolina and beyond
title_short Urgent need to expand syringe services programs in South Carolina and beyond
title_sort urgent need to expand syringe services programs in south carolina and beyond
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210717/
https://www.ncbi.nlm.nih.gov/pubmed/35729624
http://dx.doi.org/10.1186/s13011-022-00476-0
work_keys_str_mv AT phamquang urgentneedtoexpandsyringeservicesprogramsinsouthcarolinaandbeyond
AT burrowsmarc urgentneedtoexpandsyringeservicesprogramsinsouthcarolinaandbeyond
AT litwinalain urgentneedtoexpandsyringeservicesprogramsinsouthcarolinaandbeyond